Taking the frequently unimpaired growth of the primary tumor mass and of established metastases after therapeutic trials to deplete CIC markers and/or selected Tf, we expect that both stemness markers and partial EMT greatly facilitate tumor progression. Here, TF is linked to neoplasm.